Jay Messer, MD
Radiation Oncology · Austin, TXNPI 1689038051
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Teleflex LLC accounts for 77.1% of it on its own, with 32 other manufacturers making up the rest. 2025 is the largest year on record at $8,521, more than ten times the $398 reported in 2019. Among radiation oncology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 80 payments — averaging $134.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$8K
- Johnson & Johnson$450
- GT Medical Technologies, Inc$261
- Viewray Technologies Inc$167
- AstraZeneca$165
- Boston Scientific$133
- plus $1K from 27 others
What the payments were for
- Consulting fees$2,49423%
- Speaking & faculty fees$4,51342%
- Food & beverage$3,73435%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 20 | $8,277 |
| Johnson & Johnson | 5 | $450 |
| GT Medical Technologies, Inc | 3 | $261 |
| Viewray Technologies Inc | 1 | $167 |
| AstraZeneca | 3 | $165 |
| Boston Scientific | 2 | $133 |
| Progenics Pharmaceuticals, Inc. | 1 | $123 |
| Bioprotect Medical, Inc. | 1 | $115 |
| Merck | 5 | $107 |
| Isoray, Inc | 1 | $106 |
| Dendreon Pharmaceuticals LLC | 3 | $86 |
| Mirati Therapeutics, Inc. | 3 | $69 |
| Lilly USA, LLC | 3 | $62 |
| Incyte Corporation | 3 | $62 |
| Genmab U.S., Inc. | 2 | $60 |
| Seagen Inc. | 3 | $57 |
| Blue Earth Diagnostics | 2 | $50 |
| Servier Pharmaceuticals LLC | 2 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Eisai Inc. | 2 | $41 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Spectrum Pharmaceuticals Inc. | 1 | $25 |
| Novartis | 1 | $25 |
| Apellis Pharmaceuticals, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Immunogen, Inc. | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Morphosys, US Inc. | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barrigel$7,529
- RYBREVANT$227
- CARVYKTI$227
- MRIdian$167
- GammaTile$150
- UroLift$144
- TAGRISSO$125
- PYLARIFY$123
- BIOPROTECT BALLOON IMPLANT SYSTEM$115
- SpaceOAR VUE System - 10mL$113
- Brachytherapy Source$106
- Erleada$106
- AKEEGA$106
How this compares
$10,741 in reported general payments places this provider in the 90th percentile of 418 radiation oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 51 | $725 |
| Ciprofloxacin Hcl | 33 | $104 |
| Alprazolam | 50 | $30 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Austin
- James WelshHouston$421K
- Stephen ChunHouston$344K
- Jim HsiangCorpus Christi$258K
- Chad TangHouston$183K
- Phuoc TranHouston$177K
- Hak ChoyDallas$119K
- Steven LinHouston$105K
- Benjamin SchrankHouston$100K
- Robert TimmermanDallas$77K
- Abhilasha PatelHouston$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.